Nanoceria for the treatment of oxidative stress
View Patent ↗A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising cerous ion, citric acid and ethylenediaminetetraacetic acid in a predetermined ratio, an oxidant, and water is provided along with temperature conditions to directly form, without isolation, a stable dispersion of cerium oxide nanoparticles. These biocompatible cerium oxide nanoparticles may be used to prevent and/or treat oxidative stress related diseases, such as stroke, relapse/remitting multiple sclerosis, chronic-progressive multiple sclerosis, amyotrophic lateral sclerosis, and ischemic reperfusion injury.
1. A method of making a dispersion of nanoparticles, comprising:
forming a reaction mixture comprising cerous ion, citric acid and ethylenediaminetetraacetic acid in a molar ratio ranging from about 3.0 to about 0.1, an oxidant, and water;
thereby directly forming in the reaction mixture, without isolation of the nanoparticles, a dispersion of cerium-containing nanoparticles.
2. The method of claim 1 , wherein said cerium-containing nanoparticles are substantially crystalline.
3. The method of claim 2 , wherein said nanoparticles are characterized by a cubic fluorite crystal structure.
4. The method of claim 1 , further comprising heating or cooling the reaction mixture to maintain a reaction temperature less than the boiling temperature of water.
5. The method of claim 1 , wherein said oxidant comprises air, molecular oxygen or hydrogen peroxide.
6. The method of claim 1 , wherein said cerium-containing nanoparticles are substantially non-agglomerated.
7. The method of claim 6 , wherein greater than about 95 percent of said cerium-containing nanoparticles are non-agglomerated.
8. The method of claim 1 , wherein said dispersion of cerium-containing nanoparticles has a zeta-potential ranging from about −15 mV to about −30 mV.
9. The method of claim 1 , wherein said dispersion is stable for 2 to 12 months.